These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 8822919

  • 1. Hematologic effects of flt3 ligand in vivo in mice.
    Brasel K, McKenna HJ, Morrissey PJ, Charrier K, Morris AE, Lee CC, Williams DE, Lyman SD.
    Blood; 1996 Sep 15; 88(6):2004-12. PubMed ID: 8822919
    [Abstract] [Full Text] [Related]

  • 2. Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors.
    Gabbianelli M, Pelosi E, Montesoro E, Valtieri M, Luchetti L, Samoggia P, Vitelli L, Barberi T, Testa U, Lyman S.
    Blood; 1995 Sep 01; 86(5):1661-70. PubMed ID: 7544638
    [Abstract] [Full Text] [Related]

  • 3. Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice.
    Brasel K, McKenna HJ, Charrier K, Morrissey PJ, Williams DE, Lyman SD.
    Blood; 1997 Nov 01; 90(9):3781-8. PubMed ID: 9345066
    [Abstract] [Full Text] [Related]

  • 4. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta.
    Veiby OP, Jacobsen FW, Cui L, Lyman SD, Jacobsen SE.
    J Immunol; 1996 Oct 01; 157(7):2953-60. PubMed ID: 8816402
    [Abstract] [Full Text] [Related]

  • 5. Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase.
    Rappold I, Ziegler BL, Köhler I, Marchetto S, Rosnet O, Birnbaum D, Simmons PJ, Zannettino AC, Hill B, Neu S, Knapp W, Alitalo R, Alitalo K, Ullrich A, Kanz L, Bühring HJ.
    Blood; 1997 Jul 01; 90(1):111-25. PubMed ID: 9207445
    [Abstract] [Full Text] [Related]

  • 6. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG.
    Leukemia; 1996 Apr 01; 10(4):588-99. PubMed ID: 8618433
    [Abstract] [Full Text] [Related]

  • 7. Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15.
    Pierelli L, Scambia G, Bonanno G, Coscarella A, De Santis R, Mele A, Battaglia A, Fattorossi A, Romeo V, Menichella G, Mancuso S, Leone G.
    Exp Hematol; 1999 Mar 01; 27(3):416-24. PubMed ID: 10089903
    [Abstract] [Full Text] [Related]

  • 8. FLT3/FLK2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units.
    Hudak S, Hunte B, Culpepper J, Menon S, Hannum C, Thompson-Snipes L, Rennick D.
    Blood; 1995 May 15; 85(10):2747-55. PubMed ID: 7537980
    [Abstract] [Full Text] [Related]

  • 9. Marrow sensitization to 5-fluorouracil using the ligands for Flt-3 and c-Kit.
    Jin L, Neff T, Blau CA.
    Exp Hematol; 1999 Mar 15; 27(3):520-5. PubMed ID: 10089915
    [Abstract] [Full Text] [Related]

  • 10. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE, Benninger L, Cooper S, Hague N, Benjamin RS, Vadhan-Raj S.
    Exp Hematol; 1995 Apr 15; 23(4):335-40. PubMed ID: 7895781
    [Abstract] [Full Text] [Related]

  • 11. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 15; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 12. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
    Ruggieri L, Heimfeld S, Broxmeyer HE.
    Blood Cells; 1994 Dec 15; 20(2-3):436-54. PubMed ID: 7538350
    [Abstract] [Full Text] [Related]

  • 13. Synergistic effect of FLT-3 ligand on the granulocyte colony-stimulating factor-induced mobilization of hematopoietic stem cells and progenitor cells into blood in mice.
    Sudo Y, Shimazaki C, Ashihara E, Kikuta T, Hirai H, Sumikuma T, Yamagata N, Goto H, Inaba T, Fujita N, Nakagawa M.
    Blood; 1997 May 01; 89(9):3186-91. PubMed ID: 9129021
    [Abstract] [Full Text] [Related]

  • 14. Modulation of haematopoietic progenitor development by FLT-3 ligand.
    Banu N, Deng B, Lyman SD, Avraham H.
    Cytokine; 1999 Sep 01; 11(9):679-88. PubMed ID: 10479404
    [Abstract] [Full Text] [Related]

  • 15. Effects of recombinant human interleukin-3 on human hematopoietic progenitor and precursor cells in vivo.
    Ottmann OG, Ganser A, Seipelt G, Eder M, Schulz G, Hoelzer D.
    Blood; 1990 Oct 15; 76(8):1494-502. PubMed ID: 2207325
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the hematopoietic activity of flt-3 ligand and granulocyte-macrophage colony-stimulating factor acting alone or in combination.
    Robinson S, Mosley RL, Parajuli P, Pisarev V, Sublet J, Ulrich A, Talmadge J.
    J Hematother Stem Cell Res; 2000 Oct 15; 9(5):711-20. PubMed ID: 11091495
    [Abstract] [Full Text] [Related]

  • 17. The effects of human FLT3 ligand on in vitro human megakaryocytopoiesis.
    Piacibello W, Garetto L, Sanavio F, Severino A, Fubini L, Stacchini A, Dragonetti G, Aglietta M.
    Exp Hematol; 1996 Feb 15; 24(2):340-6. PubMed ID: 8641363
    [Abstract] [Full Text] [Related]

  • 18. The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors.
    Broxmeyer HE, Williams DE, Hangoc G, Cooper S, Gentile P, Shen RN, Ralph P, Gillis S, Bicknell DC.
    Blood Cells; 1987 Feb 15; 13(1-2):31-48. PubMed ID: 3499193
    [Abstract] [Full Text] [Related]

  • 19. Response of hematopoiesis to cyclophosphamide follows highly specific patterns in bone marrow and spleen.
    Sefc L, Psenák O, Sýkora V, Sulc K, Necas E.
    J Hematother Stem Cell Res; 2003 Feb 15; 12(1):47-61. PubMed ID: 12662436
    [Abstract] [Full Text] [Related]

  • 20. Mast cell growth factor (c-kit ligand) supports the growth of human multipotential progenitor cells with a high replating potential.
    Carow CE, Hangoc G, Cooper SH, Williams DE, Broxmeyer HE.
    Blood; 1991 Nov 01; 78(9):2216-21. PubMed ID: 1718490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.